The pandemic exposed existing clinical trial limitations and improved trial design by increasing focus on the prime subject of research, the patient....
The COVID-19 pandemic radically changed our perspectives on how to conduct research and clinical care, and it set the stage for data-driven biomedical research and clinical practice....
The pre-pandemic environment for clinical trials has been described as unsustainable by many observers, so the massive disruption caused by COVID-19 also presents ripe opportunities for improvement....
SMPH faculty members share their experiences related to the novel coronavirus and its ramifications on individuals, families and communities....
Human challenge clinical trials can greatly speed the selection of the most promising of COVID vaccines, providing scientific and economic benefits over uniform reliance on large field studies....
The lasting impacts of the COVID-19 pandemic will be felt for decades to come, and some of those impacts aren’t fully understood yet, especially among communities of color and the elderly....
According to GlobalData’s Clinical Trial Database, six out of the 11 planned trials disclosed in the last two weeks will be investigating Covid-19 boosters and therapeutics....
How technology can enable clinical trials participation, leading to lower participant burden and better data....
The pandemic forced clinical trial sponsors to change their processes, with a more technology-driven approach and, according to a new study by Medidata, the sector is now “stronger than ever” as a result....
COVID-19 safety precautions have been rescinded as many try to to return to a sense of pre-pandemic normalcy. But the reality of disabled and immunocompromised people remains forgotten, causing them to feel left behind and further pushed out of society, disability advocates say....
English
Español
